Theophylline

GPTKB entity

Statements (54)
Predicate Object
gptkbp:instanceOf bronchodilator
methylxanthine drug
gptkbp:ATCCode R03DA04
gptkbp:CASNumber 58-55-9
gptkbp:chemicalFormula C7H8N4O2
gptkbp:color white
gptkbp:contraindication seizure disorders
cardiac arrhythmias
gptkbp:discoveredBy gptkb:Albrecht_Kossel
gptkbp:discoveredIn 1888
gptkbp:drugInteraction gptkb:phenytoin
gptkb:erythromycin
cimetidine
ciprofloxacin
gptkbp:eliminationHalfLife 8 hours (adults)
gptkbp:excretion gptkb:kidney
gptkbp:form crystalline powder
gptkbp:foundIn gptkb:café
cocoa beans
gptkbp:hasInChIKey ZFXYFBGIUFBOJW-UHFFFAOYSA-N
gptkbp:hasSMILES Cn1cnc2c1c(=O)n(C)c(=O)n2
https://www.w3.org/2000/01/rdf-schema#label Theophylline
gptkbp:IUPACName 1,3-dimethyl-7H-purine-2,6-dione
gptkbp:KEGGID D08452
gptkbp:legalStatus prescription only (US)
gptkbp:mechanismOfAction adenosine receptor antagonist
phosphodiesterase inhibitor
gptkbp:meltingPoint 273 °C
gptkbp:MeSH_ID D013736
gptkbp:metabolism liver
gptkbp:molecularWeight 180.164 g/mol
gptkbp:pregnancyCategory C (US)
gptkbp:proteinBinding 40%
gptkbp:PubChem_CID 2153
2065
CHEMBL154
DB00277
gptkbp:relatedTo caffeine
theobromine
gptkbp:routeOfAdministration oral
intravenous
gptkbp:sideEffect gptkb:arrhythmia
nausea
vomiting
headache
seizures
insomnia
gptkbp:solubility slightly soluble
gptkbp:toxicity narrow therapeutic index
gptkbp:UNII 3G6A5W338E
gptkbp:usedFor treatment of asthma
treatment of chronic obstructive pulmonary disease
gptkbp:bfsParent gptkb:CHEBI:30713
gptkbp:bfsLayer 8